Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 27,2024 No.7 Detail

Exploring the mechanism of acute liver injury induced by Cortex dictamni based on network pharmacology and in vivo experiments

Published on Jul. 31, 2024Total Views: 374 times Total Downloads: 187 times Download Mobile

Author: HU Wenkai 1 XU Xiaomin 1 JIANG Xin 1 WO Jiameixue 1 JIA Suxia 1 LIU Shumin 2 LU Fang 2

Affiliation: 1. Graduate School, Heilongjiang University of Chinese Medicine, Harbin 150040, China 2. Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China

Keywords: Cortex dictamni Acute liver injury Network pharmacology Association network diagram Molecular docking In vivo experiments Obacunone Dictamnin Fraxinellon Limonin

DOI: 10.12173/j.issn.1008-049X.202404049

Reference: HU Wenkai, XU Xiaomin, JIANG Xin, WO Jiameixue, JIA Suxia, LIU Shumin, LU Fang.Exploring the mechanism of acute liver injury induced by Cortex dictamni based on network pharmacology and in vivo experiments[J].Zhongguo Yaoshi Zazhi,2024, 27(7):1089-1098.DOI: 10.12173/j.issn.1008-049X.202404049.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To explore the mechanism of acute liver injury induced by Cortex dictamni through network pharmacology and in vivo experiment in animal.

Methods  The chemical constituents and targets of Cortex dictamni were retrieved from TCMSP, TCMIP and SwissTargetPrediction databases, and the related targets of liver injury diseases were identified through GeneCards and CTD databases. The protein interaction network of the intersection targets was analyzed by STRING database and the core targets were selected. The GO function and KEGG pathway enrichment analysis were completed by DAVID database, and the multi-level association network diagram of "drug-component-target" was constructed by Cytoscape software. In the animal study, Cortex dictamni was administered to mice at a dosage of 92.7  g/ (kg·d) via intragastric administration, and the biological samples were collected after 7 days. The pathological changes of liver were observed by hematoxylin-eosin (HE), Masson and Oil Red O staining. The expression levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) in serum, as well as malondialdehyde (MDA), superoxide dismutase (SOD), tumor necrosis factor-α (TNF-α), and interleukin (IL)-1β in liver tissues, were quantified using enzyme-linked immunosorbent assay (ELISA). The expressions of protein kinase B1 (AKT1), IL-6, TNF-α, tumor protein p53 (TP53), cystatin 3 (CASP3), and IL-1β mRNA in liver tissues were determined using real-time quantitative reverse transcription PCR (qRT-PCR). Molecular docking was employed to verify the binding affinity of potentially toxic components to their respective targets.

Results  A total of 14 chemical constituents, 244 predicted targets and 202 intersection targets with liver injury were obtained. The GO biological process analysis mainly involved positive regulation of gene expression, negative regulation of apoptosis process. KEGG pathway enrichment analysis mainly included cancer pathway and PI3K-Akt, TNF, IL-17 signaling pathways. The pathological sections revealed severe hemorrhage, a considerable amount of hepatocyte necrosis, nuclear fragmentation or dissolution in the liver tissues of mouse with HE staining after the administration of Cortex dictamni. Masson staining showed evident fibrosis in the liver tissues, while Oil Red O staining indicated a substantial production of lipid droplets. Compared with the control group, the ELISA results demonstrated a significant increase in serum AST, ALT, ALP, LDH levels, as well as hepatic MDA, TNF-α, and IL-1β levels (P<0.05), and a decrease in hepatic SOD levels (P<0.05) in the treated group. The qRT-PCR results indicated a significant elevation in the expression levels of relevant mRNAs in the liver tissues of the treated mice (P<0.05). Molecular docking showed that the potentially toxic components of obacunone, dictamnine and fraxinellon had good binding affinity to AKT1, IL-6, TNF-α, TP53, CASP3 and IL-1β.

Conclusion  Obacunone, dictamnine, fraxinellon, and limonin might be the potential toxic components of acute liver injury induced by Cortex dictamni in mice. Cortex dictamni could act on the liver by changing the expressions of AKT1, IL-6, TNF-α, TP53, CASP3, IL-1β and other proteins, affecting energy metabolism, cell differentiation, inflammation, oxidative stress and immunity, leading to liver injury.

Full-text
Please download the PDF version to read the full text: download
References

1.李旭, 孙文松, 沈宝宇. 中药白鲜皮的本草考证 [J]. 园艺与种苗, 2023, 43(3): 48-53. [Li X, Sun WS, Shen BY. Herbal textual analysis of Dictamni cortex[J]. Horticulture  & Seed, 2023, 43(3): 48-53.] DOI: 10.16530/j.cnki.cn21-1574/s.2023.03.020.

2.Wang JB, Zhu Y, Bai ZF, et al. Guidelines for the diagnosis and management of herb-induced liver injury[J]. Chinese Journal of Integrative Medicine, 2018, 24(9): 696-706. DOI: 10.1007/s11655-018-3000-8.

3.国家药品不良反应监测中心《药品不良反应信息通报》[J]. 中国药物警戒, 2009, 6(1): 55-56. DOI: CNKI:SUN:ZGYA.0.2012-06-036.

4.范琼尹, 赵保胜, 张晶璇, 等. 痔血胶囊肝毒性药物因素分析[J]. 中国实验方剂学杂志, 2018, 24(1): 150-157. [Fan QY, Zhao BS, Zhang JX, et al. Analysis on drug factors for hepatotoxicity of Zhixue capsule[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2018, 24(1): 150-157.] DOI: 10.13422/j.cnki.syfjx. 2018010150.

5.陈剑平, 李常慧, 黄诗莹, 等. 基于成分表征和网络药理学研究黄芪丹参煎液治疗急性肾损伤的质量标志物[J]. 中国药师, 2022, 25(12): 2079-2086. [Chen  JP, Li CH, Huang SY, et al. Study on the Q-markers for Huangqi-Danshen decoction in the treatment of acute kidney injury based on constituents characterization and network pharmacology[J]. China Pharmacist, 2022, 25(12): 2079-2086.] DOI: 10.19962/j.cnki.issn1008-049X.2022.12.004.

6.谭国耀, 张庚弋, 谢子薇, 等. 基于网络药理学与分子对接探究雷公藤致心脏毒性的作用机制[J]. 中国药师, 2021, 24(11): 2024-2032. [Tan GY, Zhang GY, Xie ZW, et al. Exploration of the mechanism of cardiotoxicity induced by tripterygium wilfordii based on network pharmacology and molecular docking[J]. China Pharmacist, 2021, 24(11): 2024-2032.] DOI: 10.19962/j.cnki.issn1008-049X.2021.11.012.

7.陈心雨,赵冰洁,郑浩东,等. 基于网络药理学和细胞实验探究盐酸药根碱抗酒精性肝炎的作用机制[J]. 数理医药学杂志, 2024, 37(2): 91-99. [Chen XY, Zhao BJ, Zheng HD, et al. Mechanism of jatrorrhizine hydrochloride in anti-alcoholic hepatitis based on network pharmacology and cellular experiments[J]. Journal of Mathematical Medicine, 2024, 37(2): 91-99.] DOI: 10.12173/j.issn. 1004-4337.202310184.

8.吴凯丽. 白鲜皮肝损伤成分共价修饰肝脏蛋白过程研究[D]. 贵州遵义: 遵义医科大学, 2022. DOI: 10.27680/d.cnki.gzyyc.2022.000006.

9.Wang L, Li Z, Li L, et al. Acute and sub-chronic oral toxicity profiles of the aqueous extract of Cortex Dictamni in mice and rats[J]. Journal of Ethnopharmacology, 2014, 158 Pt A: 207-215. DOI: 10.1016/j.jep.2014.10.027.

10.冀艳花, 高晗, 常云凤, 等. 白鲜皮饮片-标准汤剂-配方颗粒的HPLC指纹图谱相关性分析[J]. 中国实验方剂学杂志, 2018, 24(18): 81-87. [Ji YH, Gao H, Chang YF, et al. Correlation analysis of HPLC fingerprint chromatograms of Dictamni cortex decoction pieces-standard decoction-dispensing granules[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2018, 24(18): 81-87.] DOI: 10.13422/j.cnki.syfjx.20181206.

11.陶雪慧, 何文媛, 王超, 等. 中药苦参、白鲜皮提取工艺及剂型研究[J]. 吉林中医药, 2018, 38(8): 958-959. [Tao XH, He WY, Wang C, et al. Study on extraction technology and formulation of Sophora flavescens and Dictamnus dasycarpus[J]. Jilin Journal of Chinese Medicine, 2018, 38(8): 958-959.] DOI: 10.13463/j.cnki.jlzyy.2018.08.026.

12.吴瑞, 苗明三, 李秀敏. 基于数据挖掘的中药治疗神经性皮炎用药规律分析[J]. 中国药师, 2021, 24(2): 344-347. [Wu R, Miao MS, Li XM, et al. Analysis of the law of chinese medicine for the therapy of neurodermatitis based on data mining[J]. China Pharmacist, 2021, 24(2): 344-347.] DOI: 10.3969/j.issn.1008-049X.2021.02.031.

13.Li Z, Wang L, Zhou J, et al. Integration of transcriptomics and metabolomics profiling reveals the metabolic pathways affected in dictamnine-induced hepatotoxicity in mice[J]. Journal of Proteomics, 2020, 213: 103603. DOI: 10.1016/j.jprot.2019.103603.

14.Lin Q, Guan H, Ma C, et al. Biotransformation patterns of dictamnine in vitro/in vivo and its relative molecular mechanism of dictamnine-induced acute liver injury in mice[J]. Environmental Toxicology and Pharmacology, 2021, 85: 103628. DOI: 10.1016/j.etap.2021.103628.

15.Niu A, Qi T. Diagnostic significance of serum type IV collagen (IVC) combined with aspartate  aminotransferase (AST)/alanine aminotransferase (ALT) ratio in liver fibrosis[J]. Ann Transl Med, 2022, 10(24): 1310. DOI: 10.21037/atm-22-5010.

16.Burke MD. Hepatic function testing[J]. Postgrad Med, 1978, 64(3): 177-182, 185. DOI: 10.1080/00325481. 1978.11714929.

17.Yuan R, Tao X, Liang S, et al. Protective effect of acidic polysaccharide from Schisandra chinensis on acute  ethanol-induced liver injury through reducing CYP2E1-dependent oxidative stress[J]. Biomed Pharmacother, 2018, 99: 537-542. DOI: 10.1016/j.biopha.2018.01.079.

18.Fan S, Zhang C, Luo T, et al. Limonin: a review of its pharmacology, toxicity, and pharmacokinetics[J]. Molecules, 2019, 24(20): 3679. DOI: 10.3390/molecules 24203679.

19.Zhou H, Liu Q, Zhang J, et al. Cytochrome P450-mediated bioactivation: implication for the liver injury induced  by fraxinellone, a bioactive constituent from dictamni cortex[J]. Chem Res Toxicol, 2020, 33(7): 1960-1968. DOI: 10.1021/acs.chemrestox.0c00141.

20.Cianciulli A, Calvello R, Porro C, et al. PI3k/Akt signalling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microglia[J]. Int Immunopharmacol, 2016, 36: 282-290. DOI: 10.1016/j.intimp.2016.05.007.

21.Reyes-Gordillo K, Shah R, Arellanes-Robledo J, et al. Akt1 and Akt2 isoforms play distinct roles in regulating the development of inflammation and fibrosis associated with alcoholic liver disease[J]. Cells, 2019, 8(11): 1337. DOI: 10.3390/cells8111337.

22.Fan Q, Zhao B, Wang C, et al. Subchronic toxicity studies of cortex dictamni extracts in mice and its potential hepatotoxicity mechanisms in vitro[J]. Molecules, 2018, 23(10): 2486. DOI: 10.3390/molecules23102486.

23.李若男, 陈喜, 赵李娜, 等. 基于网络药理学吴茱萸治疗结直肠癌作用机制探讨及实验验证[J]. 药物评价研究, 2024, 47(1): 38-45. [Li RN, Chen X, Zhao LN, et al. Mechanism of evodia rutaecarpa in treatment of colorectal cancer based on network pharmacology and experimental verification[J]. Drug Evaluation Research, 2024, 47(1): 38-45.] DOI: 10.7501/j.issn.1674-6376.2024.01.005.

24.石伟. 基于免疫应激的白鲜皮致特异质肝损伤评价及机制研究[D]. 南昌: 江西中医药大学, 2020. DOI: 10.27180/d.cnki.gjxzc.2020.000116.

Popular papers
Last 6 months